CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model.

Felce SL, Anderson AP, Maguire S, Gascoyne DM, Armstrong RN, Wong KK, Li D, Banham AH
Front Oncol. 2020 Apr 3;10:448. doi: 10.3389/fonc.2020.00448. eCollection 2020. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.